Corporate DisclosureIBNSINA
IBNSINA Corporate Disclosure — 3 January 2021
Announcement summary
- What happened
- IBNSINA published a corporate disclosure on 3 January 2021. Read the full announcement for details.
- Company
- The IBN SINA Pharmaceutical Industry PLC
- Announcement published
Original announcement
The Company has informed that the Board of Directors has decided to form a Subsidiary Company in the name of The IBN Sina Natural Medicine Ltd. aiming to comply with the legal requirements of the Directorate General of Drug Administration (DGDA), Government of Bangladesh under wholly owned investment of The IBN SINA Pharmaceutical Industry Ltd. subject to completion of all regulatory formalities and approval of the concerned regulatory authorities, (cont.)
Source & verification
- Source
- Published company disclosure
- Published through
- Dhaka Stock Exchange
- Announcement ID
- 616ace8c5a6b000040054bf6
- Original publication
- Last verified by BullBD
- Translation
- BullBD
More news from IBNSINA
Financial information is provided for general reference only and may be revised by the company. BullBD is not the official DSE website. Not investment advice.